189 related articles for article (PubMed ID: 7798789)
21. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
22. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
Bouvier C; Guc MO; Furman BL; Parratt JR
Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
[TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor reduces spinal cord blood flow and causes behavioral deficits after intrathecal administration in rats through a specific receptor mechanism.
Faden AI; Halt P
J Pharmacol Exp Ther; 1992 Jun; 261(3):1064-70. PubMed ID: 1602373
[TBL] [Abstract][Full Text] [Related]
24. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection.
Viswanath M; Palmer C; Roberts RL
Pediatr Res; 2000 Jul; 48(1):109-13. PubMed ID: 10879808
[TBL] [Abstract][Full Text] [Related]
25. Glomerular effects of cholera toxin in isolated perfused rat kidney: a potential role for platelet activating factor.
Monteiro HS; Lima AA; Fonteles MC
Pharmacol Toxicol; 1999 Sep; 85(3):105-10. PubMed ID: 10522748
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model.
Hruby ZW; Lowry RP; Forbes RD; Blais D
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):575-86. PubMed ID: 1668710
[TBL] [Abstract][Full Text] [Related]
27. Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies.
Wilson DV; Stick JA
Am J Vet Res; 1993 Mar; 54(3):443-8. PubMed ID: 8498751
[TBL] [Abstract][Full Text] [Related]
28. Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.
Gschwend S; Haug MB; Nierhaus M; Schulz A; Vetter R; Kossmehl P; Orzechowski HD; Scholze J; Rothermund L; Kreutz R
Life Sci; 2009 Sep; 85(11-12):431-7. PubMed ID: 19635487
[TBL] [Abstract][Full Text] [Related]
29. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
[TBL] [Abstract][Full Text] [Related]
30. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
Bocheński J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
[TBL] [Abstract][Full Text] [Related]
31. Dietary protein and glomerular response to subtotal nephrectomy in the rat.
Savin VJ; Seaton RD; Richardson WP; Duncan KA; Beason-Griffin C; Ahnemann J
J Lab Clin Med; 1989 Jan; 113(1):41-9. PubMed ID: 2909649
[TBL] [Abstract][Full Text] [Related]
32. Role of angiotensin II-induced renal functional changes in mesangial deposition of exogenous ferritin in rats.
Stein HD; Feddergreen W; Kashgarian M; Sterzel RB
Lab Invest; 1983 Sep; 49(3):270-80. PubMed ID: 6350702
[TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor antagonists in experimental shock.
Muacevic G; Heuer HO
Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
[TBL] [Abstract][Full Text] [Related]
34. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
35. Effects of ochratoxin A in the partially nephrectomized rat.
Stein AF; Geerling S; Mollenhauer HH; Kubena LF; Heidelbaugh ND; Phillips TD
J Toxicol Environ Health; 1984; 14(4):535-50. PubMed ID: 6512881
[TBL] [Abstract][Full Text] [Related]
36. Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys.
Kobayashi S; Hishida A
J Lab Clin Med; 1995 May; 125(5):572-80. PubMed ID: 7738423
[TBL] [Abstract][Full Text] [Related]
37. Diabetic glomerulopathy following unilateral nephrectomy in the dog.
Whiteside C; Katz A; Cho C; Silverman M
Clin Invest Med; 1990 Oct; 13(5):279-86. PubMed ID: 1703467
[TBL] [Abstract][Full Text] [Related]
38. The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury.
Stahl RA; Thaiss F; Oberle G; Brecht HM; Schoeppe W; Wenzel U; Helmchen UM
J Am Soc Nephrol; 1991 Jul; 2(1):37-44. PubMed ID: 1655092
[TBL] [Abstract][Full Text] [Related]
39. [The effect of platelet-activating factor antagonists on early bacteria translocation of rat after burn injury].
Qin X; Yu P; Yuan J
Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):217-8. PubMed ID: 7587673
[TBL] [Abstract][Full Text] [Related]
40. [Effects of reactive oxygen species scavenger and platelet activating factor receptor antagonist on accelerated nephrotoxic nephritis].
Kakuta S
Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):115-24. PubMed ID: 8315875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
